Azenta (AZTA) Net Income towards Common Stockholders (2010 - 2026)
Azenta (AZTA) recorded quarterly Net Income towards Common Stockholders of -$3.8 million in Q1 2026, up 63.12% quarter-over-quarter from -$10.2 million in Q4 2025, and up 86.45% on a YoY basis from -$2.0 million in Q1 2025.
Azenta (AZTA) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Azenta's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$3.8 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 86.45% year-over-year to -$3.8 million; the TTM figure through Mar 2026 stood at -$62.4 million (down 44.87% YoY), while the FY2025 annual figure was -$4.4 million, changed N/A from the prior year.
- Net Income towards Common Stockholders was -$3.8 million for Q1 2026 at Azenta, up from -$10.2 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $2.1 billion in Q1 2022 to a low of -$120.7 million in Q1 2024.
- Historically, Net Income towards Common Stockholders has averaged $108.9 million across 5 years, with a median of -$4.9 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders jumped 6725.67% in 2022, then slumped 4010.39% in 2024.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$11.3 million in 2022, then rose by 24.33% to -$8.5 million in 2023, then jumped by 54.07% to -$3.9 million in 2024, then sank by 161.34% to -$10.2 million in 2025, then jumped by 63.12% to -$3.8 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$3.8 million (Q1 2026), -$10.2 million (Q4 2025), and -$776000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.00 Mn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn | -3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.78 Mn |
| Dec 31, 2025 | -10.24 Mn |
| Sep 30, 2025 | -776,000.00 |
| Jun 30, 2025 | -47.66 Mn |
| Mar 31, 2025 | -27.87 Mn |
| Dec 31, 2024 | -3.92 Mn |
| Sep 30, 2024 | -4.89 Mn |
| Jun 30, 2024 | -6.42 Mn |
| Mar 31, 2024 | -120.68 Mn |
| Dec 31, 2023 | -8.53 Mn |
| Sep 30, 2023 | -4.65 Mn |
| Jun 30, 2023 | 993,000.00 |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -11.28 Mn |
| Sep 30, 2022 | -15.45 Mn |
| Jun 30, 2022 | -2.56 Mn |
| Mar 31, 2022 | 2.12 Bn |
| Dec 31, 2021 | 40.46 Mn |
| Sep 30, 2021 | 44.20 Mn |
| Jun 30, 2021 | 41.01 Mn |